Coronary artery disease and transcatheter aortic valve replacement: current treatment paradigms

Jean-Michel Paradis1, Benoit Labbé, Josep Rodés-Cabau

  • 1aQuebec Heart and Lung Institute, Quebec, Quebec, Canada bCardiovascular Research Foundation, New York, New York, USA.

Coronary Artery Disease
|January 21, 2015
PubMed

Insights

Aortic stenosis and coronary artery disease often coexist in elderly patients. This review explores management strategies for patients with both conditions, especially those undergoing transcatheter aortic valve replacement.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Valvular Heart Disease

Background:

  • Aortic stenosis is the most prevalent valvular heart disease in the elderly.
  • Coronary artery disease frequently coexists with aortic stenosis.
  • Transcatheter aortic valve replacement offers an alternative to surgery for high-risk patients.

Purpose of the Study:

  • To provide a comprehensive overview of managing coronary artery disease in patients with aortic stenosis.
  • To discuss treatment approaches for patients with concomitant aortic stenosis and coronary artery disease.
  • To address the controversial aspects of coronary artery disease management in the context of transcatheter aortic valve replacement.

Main Methods:

  • Literature review of existing studies on aortic stenosis and coronary artery disease management.
  • Analysis of treatment options for patients with combined valvular and coronary disease.
  • Synthesis of current evidence regarding transcatheter aortic valve replacement in patients with coronary artery disease.

Main Results:

  • Conflicting results exist in the literature regarding the optimal management of coronary artery disease in patients undergoing transcatheter aortic valve replacement.
  • Surgical aortic valve replacement has been the traditional treatment for aortic stenosis.
  • Transcatheter aortic valve replacement has expanded treatment options for high-risk individuals.

Conclusions:

  • The management of coronary artery disease in patients with aortic stenosis, particularly those undergoing transcatheter aortic valve replacement, requires careful consideration.
  • Further research is needed to resolve controversies in managing concomitant coronary artery disease and aortic stenosis.
  • This review proposes treatment approaches for this complex patient population.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
437
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
562
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
626
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
642
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
502
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
488